CPB Inhibitors

Chemical inhibitors of CPB can be characterized by their ability to engage with the protein's active site and alter its function through various mechanisms. Benzamidine, for instance, is a reversible inhibitor that competes with natural substrates for the active site of CPB, preventing the hydrolysis of peptide bonds, which is the fundamental action of this serine protease. Similarly, Phenylmethylsulfonyl fluoride (PMSF) and Diisopropyl fluorophosphate (DFP) act by covalently modifying the essential serine residue in the active site of CPB. This modification is stable for PMSF and results in the phosphorylation of the serine residue for DFP, both leading to the functional inhibition of CPB's enzymatic activity. Moreover, Nα-p-Tosyl-L-lysine chloromethyl ketone (TLCK) and Nα-p-Tosyl-L-phenylalanine chloromethyl ketone (TPCK) are known for their irreversible binding to this crucial serine residue, with TLCK targeting trypsin-like serine proteases and TPCK targeting chymotrypsin-like proteases, thereby preventing CPB from engaging its substrates.

The inhibitors α1-Antitrypsin and Aprotinin exert their inhibitory effect on CPB by binding directly to its active site, which stops the protein from interacting with its specific substrates. These inhibitors, like the polypeptide Aprotinin, form stable complexes that result in the blockade of the proteolytic activity of CPB. On the other hand, synthetic inhibitors like Gabexate mesilate, Nafamostat mesilate, and Camostat mesilate reversibly bind to the active site of CPB, which leads to the inhibition of the enzyme's function. These synthetic inhibitors are known for their broad specificity towards serine proteases, thus influencing CPB activity by preventing the cleavage of peptide bonds. Lastly, peptide-based inhibitors such as Leupeptin and Antipain interact with CPB by covalently binding to the serine residue within the active site, thus offering a temporary or permanent inactivation of the protein's proteolytic function, respectively. These inhibitors achieve their effect by obstructing the access of natural substrates to the active site of CPB, ensuring the inhibition of its enzymatic activity.